Watch out, watch out, the FDA are about
Open Access
- 15 May 2008
- journal article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 50 (6) , 408-409
- https://doi.org/10.1111/j.1469-8749.2008.00408.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Testing the SF-36 in Parkinson's diseaseZeitschrift für Neurologie, 2008
- Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendationsThe Lancet Neurology, 2007
- FDA draft guidance and health-outcomes researchThe Lancet, 2007
- Evidence‐based guidelines for using the Short Form 36 in cervical dystoniaMovement Disorders, 2007
- Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth and Quality of Life Outcomes, 2006
- Quality of Life Measurement After StrokeStroke, 2002
- Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptionsZeitschrift für Neurologie, 2002
- The SF-36 in multiple sclerosis: why basic assumptions must be testedJournal of Neurology, Neurosurgery & Psychiatry, 2001